Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Bladder Cancer

  Free Subscription


05.03.2018

1 Adv Med Sci
2 Ann Surg Oncol
1 ANZ J Surg
1 Asian Pac J Cancer Prev
1 BJU Int
1 BMJ Open
1 Bull Cancer
1 Can Urol Assoc J
1 Cancer Immunol Immunother
1 Cancer Med
1 Eur Urol Focus
1 Hinyokika Kiyo
1 Int J Med Sci
1 Int J Oncol
1 Int J Radiat Oncol Biol Phys
1 Int J Urol
1 Int Urol Nephrol
1 J Cachexia Sarcopenia Muscle
1 J Evid Based Med
1 J Urol
1 Lasers Med Sci
3 Oncol Lett
2 Oncotarget
1 Rev Urol
1 Transl Oncol
1 Turk J Urol
7 Urol Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Adv Med Sci

  1. MIRZAEI MR, Mahmoodi M, Hassanshahi G, Ahmadi Z, et al
    Down-regulation of anti-apoptotic genes in tumor cell lines is facilitated by suppression of OCT4B1.
    Adv Med Sci. 2017;62:97-102.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. GROEBEN C, Koch R, Baunacke M, Schmid M, et al
    Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014.
    Ann Surg Oncol. 2018 Feb 21. pii: 10.1245/s10434-018-6381.
    PubMed     Text format     Abstract available

  3. TEOH JY, Chan ES, Yip SY, Tam HM, et al
    Comparison of Detrusor Muscle Sampling Rate in Monopolar and Bipolar Transurethral Resection of Bladder Tumor: A Randomized Trial.
    Ann Surg Oncol. 2017;24:1428-1434.
    PubMed     Text format     Abstract available


    ANZ J Surg

  4. MAO SY, Xiong DB, Huang TB, Zheng JH, et al
    Expression of CUL1 correlates with tumour-grade and recurrence in urothelial carcinoma.
    ANZ J Surg. 2017;87.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  5. BAGREZAEI F, Hassanshahi G, Mahmoodi M, Khanamani Falahati-Pour S, et al
    Expression of Inhibitor of Apoptosis Gene Family Members in Bladder Cancer Tissues and the 5637 Tumor Cell Line
    Asian Pac J Cancer Prev. 2018;19:529-532.
    PubMed     Text format     Abstract available


    BJU Int

  6. THALMANN GN
    Quality improvement in cystectomy care with enhanced recovery (QUICCER) study.
    BJU Int. 2017;119:4-5.
    PubMed     Text format    


    BMJ Open

  7. MOLLER KL, Brauer C, Mikkelsen S, Loft S, et al
    Copenhagen Airport Cohort: air pollution, manual baggage handling and health.
    BMJ Open. 2017;7:e012651.
    PubMed     Text format     Abstract available


    Bull Cancer

  8. BERNARD-TESSIER A, Bonnet C, Lavaud P, Gizzi M, et al
    [Atezolizumab (Tecentriq((R))): Activity, indication and modality of use in advanced or metastatic urinary bladder carcinoma].
    Bull Cancer. 2018;105:140-145.
    PubMed     Text format     Abstract available


    Can Urol Assoc J

  9. RICHARD PO, Ahmad AE, Bashir S, Zlotta A, et al
    Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A population-based analysis.
    Can Urol Assoc J. 2018 Feb 23. pii: cuaj.4870. doi: 10.5489/cuaj.4870.
    PubMed     Text format     Abstract available


    Cancer Immunol Immunother

  10. SHAN G, Tang T, Qian H, Xia Y, et al
    Certain BCG-reactive responses are associated with bladder cancer prognosis.
    Cancer Immunol Immunother. 2018 Feb 24. pii: 10.1007/s00262-018-2127.
    PubMed     Text format     Abstract available


    Cancer Med

  11. TANG H, Shi W, Fu S, Wang T, et al
    Pioglitazone and bladder cancer risk: a systematic review and meta-analysis.
    Cancer Med. 2018 Feb 24. doi: 10.1002/cam4.1354.
    PubMed     Text format     Abstract available


    Eur Urol Focus

  12. MULDERS PFA, Martinez-Pineiro L, Heidenreich A, Babjuk M, et al
    Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial.
    Eur Urol Focus. 2018 Feb 21. pii: S2405-4569(18)30033.
    PubMed     Text format     Abstract available


    Hinyokika Kiyo

  13. MITA K, Kobatake K, Ohara S, Kato M, et al
    [Clinical Benefits of Transurethral Resection Under Narrow Band Imaging for Non-Muscle Invasive Bladder Cancer].
    Hinyokika Kiyo. 2018;64:1-6.
    PubMed     Text format     Abstract available


    Int J Med Sci

  14. YANG SL, Wang JJ, Chen M, Xu L, et al
    Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.
    Int J Med Sci. 2018;15:228-237.
    PubMed     Text format     Abstract available


    Int J Oncol

  15. DU P, Ye L, Yang Y, Jiang WG, et al
    [Corrigendum] Candidate of metastasis 1 regulates in vitro growth and invasion of bladder cancer cells.
    Int J Oncol. 2018 Feb 16. doi: 10.3892/ijo.2018.4277.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  16. BAJAJ A, Martin B, Bhasin R, Hentz C, et al
    The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2018;100:851-857.
    PubMed     Text format     Abstract available


    Int J Urol

  17. OTTO W, van Rhijn BW, Breyer J, Bertz S, et al
    Infiltrative lamina propria invasion pattern as an independent predictor for cancer-specific and overall survival of instillation treatment-naive stage T1 high-grade urothelial bladder cancer.
    Int J Urol. 2018 Feb 22. doi: 10.1111/iju.13532.
    PubMed     Text format     Abstract available


    Int Urol Nephrol

  18. ZHANG J, Wang L, Mao S, Liu M, et al
    Transurethral en bloc resection with bipolar button electrode for non-muscle invasive bladder cancer.
    Int Urol Nephrol. 2018 Feb 24. pii: 10.1007/s11255-018-1830.
    PubMed     Text format     Abstract available


    J Cachexia Sarcopenia Muscle

  19. MAYR R, Gierth M, Zeman F, Reiffen M, et al
    Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer.
    J Cachexia Sarcopenia Muscle. 2018 Feb 25. doi: 10.1002/jcsm.12279.
    PubMed     Text format     Abstract available


    J Evid Based Med

  20. ZENG XT, Liu TZ, Gong K, He DL, et al
    The BPSC: A prospective study investigating the clinical effect of interventional therapy and the risk factors for bladder cancer and benign prostatic hyperplasia in Chinese population.
    J Evid Based Med. 2018;11:64-67.
    PubMed     Text format     Abstract available


    J Urol

  21. UHLIG A, Amir Hosseini AS, Simon J, Lotz J, et al
    Gender-specific differences in disease-free, cancer-specific and overall survival after radical cystectomy for bladder cancer: a systematic review and meta-analysis.
    J Urol. 2018 Feb 22. pii: S0022-5347(18)39380-7. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available


    Lasers Med Sci

  22. YANG H, Wang N, Han S, Male M, et al
    Comparison of the efficacy and feasibility of laser enucleation of bladder tumor versus transurethral resection of bladder tumor: a meta-analysis.
    Lasers Med Sci. 2017;32:2005-2012.
    PubMed     Text format     Abstract available


    Oncol Lett

  23. ZHU J, Huang Z, Zhang M, Wang W, et al
    HIF-1alpha promotes ZEB1 expression and EMT in a human bladder cancer lung metastasis animal model.
    Oncol Lett. 2018;15:3482-3489.
    PubMed     Text format     Abstract available

  24. XU T, Du XW, Hu JB, Zhu YF, et al
    Anticancer effect of miR-96 inhibitor in bladder cancer cell lines.
    Oncol Lett. 2018;15:3814-3819.
    PubMed     Text format     Abstract available

  25. ZHANG X, Chen Y, Dong L, Shi B, et al
    Effect of selective inhibition of aquaporin 1 on chemotherapy sensitivity of J82 human bladder cancer cells.
    Oncol Lett. 2018;15:3864-3869.
    PubMed     Text format     Abstract available


    Oncotarget

  26. MASUDA N, Ogawa O, Park M, Liu AY, et al
    Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer.
    Oncotarget. 2018;9:7101-7111.
    PubMed     Text format     Abstract available

  27. LEE MS, Lee J, Lee S, Yoo SM, et al
    Clinical, prognostic, and therapeutic significance of heat shock protein 27 in bladder cancer.
    Oncotarget. 2018;9:7961-7974.
    PubMed     Text format     Abstract available


    Rev Urol

  28. NEAL DS
    Are You Developing an ABC: Advanced Bladder Cancer Clinic?
    Rev Urol. 2017;19:246-247.
    PubMed     Text format    


    Transl Oncol

  29. KRIEGMAIR MC, Wirtz RM, Worst TS, Breyer J, et al
    Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer.
    Transl Oncol. 2018;11:467-476.
    PubMed     Text format     Abstract available


    Turk J Urol

  30. BOYUK A, Sanli O, Erdem S, Tefik T, et al
    The association between variant urothelial histologies, pathological stage and disease specific survival in patients with bladder cancer.
    Turk J Urol. 2018;44:24-30.
    PubMed     Text format     Abstract available


    Urol Oncol

  31. PACKIAM VT, Agrawal VA, Cohen AJ, Pariser JJ, et al
    Lessons from 151 ureteral reimplantations for postcystectomy ureteroenteric strictures: A single-center experience over a decade.
    Urol Oncol. 2017;35:112.
    PubMed     Text format     Abstract available

  32. CHENG ML, Iyer G
    Novel biomarkers in bladder cancer.
    Urol Oncol. 2018 Feb 19. pii: S1078-1439(18)30009.
    PubMed     Text format     Abstract available

  33. SONG W, Sung HH, Han DH, Jeong BC, et al
    The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer.
    Urol Oncol. 2017;35:114.
    PubMed     Text format     Abstract available

  34. FROEHNER M, Koch R, Heberling U, Novotny V, et al
    An easily applicable single condition-based mortality index for patients undergoing radical prostatectomy or radical cystectomy.
    Urol Oncol. 2017;35:32.
    PubMed     Text format     Abstract available

  35. LU DD, Boorjian SA, Raman JD
    Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists.
    Urol Oncol. 2017;35:113.
    PubMed     Text format     Abstract available

  36. CHAPPIDI MR, Chalfin HJ, Johnson DJ, Kates M, et al
    Longer average blood storage duration is associated with increased risk of infection and overall morbidity following radical cystectomy.
    Urol Oncol. 2017;35:38.
    PubMed     Text format     Abstract available

  37. MYLONAS KS, O Malley P, Ziogas IA, El-Kabab L, et al
    Malignant urachal neoplasms: A population-based study and systematic review of literature.
    Urol Oncol. 2017;35:33.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: